Marrow cells from male mice pretreated with 5-fluorouracil were infected with helper-free neomycinresistant (neor) recombinant retrovirus and then used to initiate long-term cultures (LTC) on irradiated adherent marrow feeder layers. Four weeks later LTC cells were harvested and injected into lethally irradiated female recipients either alone or together with 2 x 105 female marrow cells with selectively compromised long-term repopulating potential to assay for totipotent and competitive repopulating units (CRU), respectively. A total of 46 unique clones were detected in recipients 5 wk to 7 mo after transplant. Half of these clones (22 of 46) included both lymphoid and myeloid progeny. Eight of the 22 lympho-myeloid clones were represented in multiple recipients, in some cases after ijfection of limiting numbers of CRU, thus indicating repopulation from sibling totipotent stem cells generated during the initial 4-wk period in LTC. Serial analysis of cells released into the nonadherent fraction of LTC for up to 7 wk provided additional evidence of the continuing proliferation in LTC of totipotent stem cells with long-term repopulating potential. The frequency of CRU determined from limiting-dilution analyses ofLTC-derived cells was the same for recipients analyzed at 5 wk or 7 mo after transplantation and was also the same whether marrow or thymus repopulation was assessed. These assays showed that concurrent with the expansion of some totipotent cells revealed by retroviral marking, there was a slow but net 6.5-fold decrease in total CRU numbers after 4 wk in LTC. These results show the capacity of some totipotent hematopoietic stem cells to be maintained and amplified over extensive time periods in vitro without diminution of their long-term in vivo repopulating potential. These results also set the stage for analogous studies of human stem cell selection and expansion in vitro, which may be important for future gene therapy protocols.
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The regenerative capacity and life-long maintenance of the hematopoietic system depends on a primitive subpopulation of stem cells with extensive self-renewal, proliferative, and differentiation potential. Totipotent hematopoietic stem cells that can clonally repopulate lymphoid and myeloid tissues in myelo-ablated recipients have been documented in both mouse and human by several experimental strategies. These strategies include the use of radiation-induced chromosomal markers (1), naturally occurring genetic markers (2, 3) , and markers introduced by retroviral insertion (4) (5) (6) (7) (8) (9) (10) . Although such cells may represent the most primitive hematopoietic population in adult marrow, considerable evidence points to a hierarchy of transplantable hematopoietic cells with different potentials for sustaining hematopoiesis in vivo (11) (12) (13) (14) (15) (16) .
Cells with long-term hematopoietic reconstituting ability can be distinguished by a number of physical and biological properties from cells that generate mature progeny in shortterm in vivo or in vitro clonogenic assays (17) (18) (19) (20) (21) (22) . Time course studies of the pattern of hematopoietic reconstitution in recipients of retrovirally marked cells have revealed frequent examples of long-term reconstitution by small numbers of totipotent stem cells under conditions where multiple, fluctuating short-lived clones are seen for up to 4 mo after transplantation (23, 24) . These results are consistent with a hierarchical structure in the stem cell populations transplanted, although they also do not exclude that environmental or stochastic mechanisms may lead to heterogeneity in the behavior exhibited by biologically similar primitive hematopoietic cells.
Methods for maintaining, expanding, and following the fate of the most primitive hematopoietic cells in vitro represent key requirements for investigating these questions. A system for the long-term culture (LTC) of mouse bone marrow introduced by Dexter et al. (25) has been shown to maintain cells capable of lymphoid and myeloid reconstitution in irradiated recipients (26) , although a diminution in colonyforming unit-spleen (CFU-S) self-renewal capacity (27) and competitive erythroid repopulating ability (28) of LTCderived cells compared with fresh marrow cells has been reported. In this study we have combined the use of a quantitative assay for competitive repopulating units (CRU) with retroviral marking of the initial cell population to demonstrate the ability of totipotent hematopoietic cells with long-term (7 mo) repopulating ability to undergo extensive amplification as their overall numbers decline over a period of 4 wk in the LTC system. MATERIALS AND METHODS Virus. Recombinant Tkneol9 virus at a titer of 1 x 106 per ml was generated from a T-2 producer line maintained in 10% calf serum/Dulbecco's modified Eagle's medium (26) . Ab female B6C3F1 marrow cells that had been previously subjected to two cycles of transplantation and regeneration were also injected to allow quantitative measurements of CRU in the retrovirally marked test cells to be obtained (29, 30) . For cultures that were used to assess recovery of repopulating cells in the nonadherent fraction over time, all of the medium and nonadherent cells were removed weekly and replaced either with fresh medium alone or with LTC medium containing 25 units per ml of recombinant mouse interleukin-3 (IL-3) (Biogen). The nonadherent cells removed after 3, 5, 6, and 7 weeks of culture were then injected into irradiated recipients. Hematopoietic Tissue Analysis. Recipients were sacrificed either 5 wk or between 5 and 7 mo after transplantation of cultured cells. DNA was routinely extracted from marrow, spleen, and thymus. In some cases, DNA was also extracted from lymph nodes and from various subpopulations of marrow and spleen. Highly enriched (>90%) mast cell populations were generated by culturing marrow or spleen cells for 3 wk in WEHI-3B-supplemented medium (as a source of IL-3), and highly enriched (>95% Mac-i-positive) macrophage populations were generated by culturing marrow or spleen cells for 48 hr in medium supplemented with 10% WEHI-3B-conditioned medium and then for 7-10 days in medium supplemented with 35% human leukocyte-conditioned medium.
Highly enriched (>90% Thy-i-positive) T-cell populations were obtained by elution of nonadherent cells after loading of a half-spleen equivalent onto a 3-ml nylon wool column and incubating it for 1 hr at 37°C (31) . Nylon wool adherent cells were then released by gentle agitation for 2-3 min in phosphate-buffered saline/10 mM EDTA and a highly enriched (>90% B220-positive) population of B lymphocytes subsequently isolated from this fraction by panning for 1 hr at 37°C in dishes precoated with unpurified rabbit anti-mouse immunoglobulin (<108 cells per dish) and selective removal of the adherent cells (32) .
Southern Blot Analysis. High-molecular-weight DNA was digested with HindIII or EcoRI, which cuts once in the proviral genome and releases a fragment unique to the integration site. Ten micrograms of digested DNA (5 ,g for male control lanes) was electrophoresed and analyzed by Southern blotting (33) as described (29) with a 32P-labeled probe specific for the neor gene sequence in the provirus from plasmid pMC1 (34) . HindIII-digested blots were stripped and reprobed with a Y chromosome-specific fragment from plasmid pY2 (20, 29, 35) .
RESULTS
In Vitro Recovery of Long-Term Repopulating Cells. To determine whether totipotent cells capable of long-term repopulation could be demonstrated in 4-wk-old LTC initiated with retrovirally infected 5-FU cells, aliquots were injected into irradiated recipients. These mice were then sacrificed 5 mo later and assessed for the presence of common clones of LTC-derived cells in various myeloid and lymphoid cell populations. Results from two representative recipients are shown in Fig. 1 A and B. Fig. 1A shows the presence of a dominant clone in both myeloid (unseparated marrow, marrow-derived mast cells, and marrow-or spleen-derived macrophages) and lymphoid cell populations (isolated splenic T and B cells, as well as thymus and lymph node cells).
Comparison of the intensity of the provirus band with that seen in a clonally derived 3T3 cell line generated after infection with the same virus indicates that the retrovirally marked stem cell clone in this mouse was contributing to at least 80% of total hematopoiesis at sacrifice. In the other mouse shown (Fig. 1B) Cell Biology: Fraser et al. after 4 wk in LTC of 6.5-fold is apparent (1/2000 in day-4 5-FU marrow vs. 1/13,000 in 4-wk-old LTC based on pooled data for bone marrow and thymus). In two experiments, CRU frequencies in the 4-wk-old LTC were also determined in additional recipients given aliquots of the same cells but sacrificed 7 mo after transplant. Because fewer recipients were available for evaluation at this later time, the derived CRU frequencies are less precise. Nevertheless, the CRU values from 7-mo tissue repopulation data were again not significantly different whether marrow or thymus was analyzed and were also not significantly different from the values obtained from mice analyzed only 5 wk after transplant ( Table 1) .
Evidence of Totipotent Stem Cell Amplification in Vitro. Because all LTC in these studies were established with retrovirally infected 5-FU marrow cells and the contents of individual cultures were then assayed in multiple recipients, the number and distribution of marked clones in different animals could be determined and, in some cases, the patterns observed could be related to the number of CRU injected. Table 2 summarizes the characteristics of all marked clones regenerated in recipients of cells from eight individual 4-wk LTC individually assayed in multiple recipients. Of a total of 46 specifically identifiable clones, nine were seen to contribute to repopulation of two or more mice, and eight of these clones included clones that repopulated both myeloid and lymphoid tissues (amplified clones I-IX, Table 2 ). A further 37 clones were identified in only one recipient, but 14 of these clones showed contributions to both myeloid and lymphoid tissues (single clones, Table 2 ). Fig. 3 shows four examples of a common clone contributing to the hematopoietic reconstitution of multiple recipients of cells from a single flask, indicating amplification of totipotent stem cells in the original retrovirus-infected input population. For simplicity we will refer to such clones as sibling stem cell clones because they are derived from a single parental precursor. Fig. 3A shows an experiment in which reconstitution of lymphoid and/or myeloid tissues by sibling clones (clone VII in Table 2 ) was detected in two CRU assay mice sacrificed 5 wk after transplant (mouse 1/150A and mouse 1/iSOB) as well as in two of six recipients injected with cells from the same LTC (1/20th of a flask), but without additional compromised cells, and sacrificed 7 mo after transplant (mouse 1/20A and mouse 1/20B). Mouse 1/iSOB, which was competitively repopulated after injection of limiting numbers of CRU (two per recipient) demonstrates repopulation of marrow, spleen, and thymus by a common stem cell. In mouse 1/150A and in mouse 1/20A, cells with the same clonal marker were detectable only in the marrow and spleen. In mouse 1/20B, the sibling clone detected appeared restricted to the spleen and thymus.
Further evidence of expansion of totipotent stem cells in LTC is provided by the recipient data shown in Fig. 3B . Here, analysis oftissues from two mice that had been injected under competitive conditions with approximately two CRU from the same flask revealed progeny of sibling clones (clone V in Table 2 ) in the marrow, spleen, and thymus at both 5 wk and 7 mo after transplant. These results also extend the CRU quantitation studies indicating detection of the same type of totipotent cell at either 5 wk or 7 mo after transplant when the CRU assay is used.
In recipients of cells from some LTC, analysis of retroviral insertion fragments revealed marked sibling clones that -C) . In the latter case 1/45, 1/150, or 1/450 of the original LTC was injected, and this amount corresponded to transplantation of -6, 2, or 0.7 CRU, respectively, per recipient. Mice in A and B were sacrificed at the times shown and in C and D at 5 wk and 7 mo after transplant, respectively. Bone marrow (B), spleen (S), and thymus (T) DNA were assessed for proviral integration sites by digestion with HindIII and hybridization to a neo-specific probe. Blots were re-probed with the Y-specific pY2 probe for assessment of donor origin. M is a control lane as described for Fig. 1. showed a predominant or restricted distribution to either lymphoid or myeloid tissues. An example of two apparently lymphoid-predominating sibling clones is presented in Fig.  3C (clone IV in Table 2 ). Even though mouse A in this figure received 10 times as many LTC cells as mouse B, in both mice the presence of marked and male cells was readily apparent only in the spleen and thymus. In a longer x-ray exposure this clone was detected at low levels in the marrow of mouse 1/45A. This result suggests a greatly diminished myeloidrepopulating capacity in the cells harvested from this particular LTC, reconstitution of the recipients' marrow thus depending on the activity of residual host cells. Fig. 3D suggests the presence of apparently myeloid-restricted sibling clones (clone VIII in Table 2 (Fig. 4A ) and by three of the nine mice reconstituted by cells from the other LTC (Fig. 4B) . At early time points [wk 3 and 5 ( Fig. 4A ) and wk 3 ( Fig. 4B) (50O, Table 2 ) were represented in both lymphoid and myeloid populations at analysis. In some instances this result occurred even when limiting numbers of CRU were injected (-two cells per recipient), thus providing direct evidence of totipotent stem cell maintenance in LTC.
The repeated demonstration of the same retroviral insertion fragments in hematopoietic tissues of different mice injected with cells from the same LTC further showed that at least some of the totipotent cells in day-4 5-FU marrow undergo clonal expansion in vitro with preservation of both their long-term and competitive lymphoid-and myeloidrepopulating ability. The fact that such marked sibling clones could be detected in CRU assay recipients of -two CRU assessed either 5 wk or 7 mo after transplant is consistent with previous evidence that CRU in day-4 5-FU marrow can be readily infected with the supernatant procedure used and that most, if not all, CRU are totipotent cells capable of sustaining hematopoiesis for at least 7 mo. This hypothesis is further supported by the finding of the same CRU frequency regardless of time of recipient assessment from 5 wk to 7 mo after transplant and regardless of whether the marrow or thymus was used to assess repopulating potential. Thus, the transplant conditions embodied in the CRU assay allow stem cells with long-term repopulating potential to be accurately quantitated as early as 5 wk after transplant. Unlike previous studies in which severe combined immunodeficiency (scid) mice were used as recipients for stem cell quantitation (36), we did not find enrichment in LTC of repopulating stem cells with lymphoid-restricted differentiation potential. Neither, however, did we observe a consistent decline in the number of repopulating stem cells active at 5 wk and 7 mo after transplant as described (24) . One explanation for both of these differences is that the number and genotype of cells present during the initial period of hematologic recovery may influence both type of progeny produced and rapidity with which they appear. Evidence in support of this possibility comes from the different rates of appearance of + /+ cells in deficient lineages after their transplantation into W/W' mice (37) . In addition, allophenic mice created from two differing genotypes show a consistently unequal contribution of each genotype to hematopoiesis (10) .
Quantitation of CRU numbers after 4 wk in LTC revealed a slow decline to -15% of the input value. Because a high proportion of those present after 4 wk could be shown to represent clonal derivatives of initially marked CRU, the behavior of individual CRU in LTC may be very heterogeneous: some undergo extensive amplification even in the face of concurrent mechanisms leading to a net loss of CRU, presumably due to their differentiation and/or death. Evidence for the continuous turnover and self-renewal of totipotent stem cells in LTC over several weeks was also demonstrated by analysis of mice injected with serially sampled nonadherent LTC cells. These results, thus, provide an important starting point for further delineation of the molecular mechanisms that support totipotent hematopoietic stem cell self-renewal in vitro and of potential effects of clonal expansion on the subsequent proliferative and developmental capacity of individual stem cells. Such experiments should be aided by the recent development of methods for attaining even higher levels of gene transfer efficiency to repopulating cells (38) .
The present studies also have implications for clinical bone marrow transplantation. Persistence in LTC of very primitive human hematopoietic cells with long-term in vitro repopulating ability has been shown to be analogous to the kinetics of CRU maintenance in murine LTC described here (39) , and it is not unreasonable to assume the operation in human LTC of similarly competing mechanisms of stem cell proliferation and decline. It should, therefore, also be possible by appropriate manipulation to optimize conditions that favor expansion of transplantable human hematopoietic stem cells in vitro, particularly where selection of clones over prolonged periods may be therapeutically advantageous-for example, for certain gene therapy protocols. 
